Flomics
1 known investors
Flomics develops liquid biopsy diagnostics that detect disease signatures in blood by combining next-generation sequencing of cell-free RNA with machine learning models. The company focuses on RNA-based biomarkers and bioinformatics for earlier cancer detection.
Investors Β· 1
Frequently asked questions
- What does Flomics do?
- Flomics develops liquid biopsy diagnostics that detect disease signatures in blood by combining next-generation sequencing of cell-free RNA with machine learning models. The company focuses on RNA-based biomarkers and bioinformatics for earlier cancer detection.
- Who are Flomics's investors?
- Flomics's investors include Capital Cell.